Vanguard Group Inc Adaptive Biotechnologies Corp Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Vanguard Group Inc holds 11,143,428 shares of ADPT stock, worth $106 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,143,428
Previous 10,714,888 4.0%
Holding current value
$106 Million
Previous $64.3 Million 28.79%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$6.07 - $8.66 $2.6 Million - $3.71 Million
428,540 Added 4.0%
11,143,428 $82.8 Million
Q4 2024

Feb 11, 2025
BUY
$4.37 - $6.78 $329,707 - $511,537
75,448 Added 0.71%
10,714,888 $64.3 Million
Q3 2024

Nov 13, 2024
BUY
$3.37 - $5.12 $1.39 Million - $2.11 Million
412,529 Added 4.03%
10,639,440 $54.5 Million
Q2 2024

Aug 13, 2024
SELL
$2.34 - $3.96 $6.18 Million - $10.5 Million
-2,642,907 Reduced 20.54%
10,226,911 $37 Million
Q1 2024

May 10, 2024
BUY
$2.88 - $4.8 $294,145 - $490,243
102,134 Added 0.8%
12,869,818 $41.3 Million
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $1.79 Million - $2.76 Million
518,642 Added 4.23%
12,767,684 $62.6 Million
Q3 2023

Nov 14, 2023
BUY
$5.07 - $8.44 $996,533 - $1.66 Million
196,555 Added 1.63%
12,249,042 $66.8 Million
Q2 2023

Aug 14, 2023
BUY
$6.19 - $8.78 $464,701 - $659,140
75,073 Added 0.63%
12,052,487 $80.9 Million
Q1 2023

May 15, 2023
BUY
$7.8 - $10.11 $1.43 Million - $1.85 Million
183,246 Added 1.55%
11,977,414 $106 Million
Q4 2022

Feb 10, 2023
BUY
$6.26 - $9.34 $766,130 - $1.14 Million
122,385 Added 1.05%
11,794,168 $90.1 Million
Q3 2022

Nov 14, 2022
BUY
$6.5 - $12.67 $620,158 - $1.21 Million
95,409 Added 0.82%
11,671,783 $83.1 Million
Q2 2022

Aug 12, 2022
BUY
$6.4 - $14.73 $3.11 Million - $7.15 Million
485,540 Added 4.38%
11,576,374 $93.7 Million
Q1 2022

May 13, 2022
BUY
$10.12 - $28.9 $602,605 - $1.72 Million
59,546 Added 0.54%
11,090,834 $154 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $1.02 Million - $1.5 Million
40,615 Added 0.37%
11,031,288 $310 Million
Q3 2021

Nov 12, 2021
BUY
$30.02 - $39.87 $24.4 Million - $32.4 Million
813,014 Added 7.99%
10,990,673 $374 Million
Q2 2021

Aug 13, 2021
BUY
$32.22 - $44.59 $328 Million - $454 Million
10,177,659 New
10,177,659 $416 Million

Others Institutions Holding ADPT

# of Institutions
246
Shares Held
156M
Call Options Held
44.3K
Put Options Held
47.8K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.36B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email